HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells.

Abstract
The prevalence of atopic asthma, a Th2-dependent disease, is reaching epidemic proportions partly due to improved hygiene in industrialized countries. There is an inverse correlation between the level of environmental endotoxin exposure and the prevalence of atopic sensitization. As dendritic cells (DC) have been implicated in causing sensitization to inhaled Ag, we studied the effect of endotoxin on Th2 development induced by bone marrow DC in vitro and by intratracheal injection in vivo, with particular emphasis on the role played by the polarizing cytokine IL-12. Bone marrow-derived DC stimulated with Escherichia coli O26:B6 LPS produced IL-12p70 for a limited period of time, after which production became refractory to further stimulation with CD40 ligand, a phenomenon previously called "exhaustion." The level of IL-12 production of DC did not correlate with Th1 development, as exhausted OVA-pulsed DC were still capable of shifting the cytokine pattern of responding OVA-specific Th cells toward Th1 in vitro and in vivo. When mice were first immunized by intratracheal injection of OVA-DC and subsequently challenged with OVA aerosol, prior in vitro stimulation of DC with LPS reduced the development of airway eosinophilia and Th2 cytokine production. Most surprisingly, the capacity of LPS to reduce Th2-dependent eosinophilic airway inflammation was IL-12-independent altogether, as IL-12p40 knockout DC had a similar reduced capacity to prime for Th2 responses. These results suggest that LPS reduces sensitization to inhaled Ag by reducing DC-driven Th2 development, but that IL-12 is not necessary for this effect.
AuthorsHarmjan Kuipers, Daniëlle Hijdra, Victor C De Vries, Hamida Hammad, Jan-Bas Prins, Anthony J Coyle, Henk C Hoogsteden, Bart N Lambrecht
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 171 Issue 7 Pg. 3645-54 (Oct 01 2003) ISSN: 0022-1767 [Print] United States
PMID14500662 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes, T-Lymphocyte
  • Growth Inhibitors
  • Immunosuppressive Agents
  • Lipopolysaccharides
  • Protein Subunits
  • Interleukin-12
  • Ovalbumin
Topics
  • Adoptive Transfer
  • Animals
  • Bone Marrow Cells (immunology, metabolism)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Differentiation (immunology)
  • Cell Division (immunology)
  • Cell Movement (immunology)
  • Cells, Cultured
  • Dendritic Cells (cytology, immunology, metabolism)
  • Epitopes, T-Lymphocyte (immunology)
  • Female
  • Growth Inhibitors (administration & dosage)
  • Immunosuppressive Agents (administration & dosage, pharmacology)
  • Interleukin-12 (biosynthesis, genetics, physiology)
  • Lipopolysaccharides (administration & dosage, pharmacology)
  • Lung (cytology, immunology, metabolism)
  • Lymphocyte Activation (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Mice, Transgenic
  • Ovalbumin (administration & dosage, immunology)
  • Protein Subunits (biosynthesis, genetics, physiology)
  • Pulmonary Eosinophilia (immunology, pathology, prevention & control)
  • T-Lymphocyte Subsets (cytology, immunology, transplantation)
  • Th2 Cells (cytology, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: